obesity therapies, including Semaglutide and Orforglipron, providing robust support for BLX-7006's potential as a transformative treatment for obesity & diabetic indications. The newly completed study builds upon a previous DIO study in which...
compensate for sphincter insufficiency in patients, both men and women, with SUI. It is based on a unique mechatronic platform using embedded smart, digital and robotic systems which, based on data collected from a patient, create a treatment...
research career at Rockefeller University. I was investigating a fundamental question: How do 100 billion connections form in our brain to empower humans to do everything we do? That led me to an interest in ophthalmology, especially retina...
immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Lecanemab is approved in the U.S., Japan, China, South Korea, Hong Kong, Israel, United Arab Emirates and...
as Fast Track designation by the FDA. The company has built a strong pipeline by leveraging its proprietary technology platforms: PACbody®, SPECpair® and ATACCbody® to develop novel biologics that address high unmet medical needs in cancer. For...
exceed expectations and mark a significant milestone in the continued development of ST-001. ST-001 Clinical Trial Information: SciTech's initial trial is targeting T-cell non-Hodgkin lymphoma (T-cell NHL) indications including all sub-types of...
Eisai having final decision-making authority. In South Korea, Eisai Korea Inc. will distribute the product and conduct information provision activities. Eisai Korea Inc. has been a pioneer in the field of dementia for many years, focusing on...
of innovative I&I biological products. We look forward to his contributions and insights as we strive to bring transformative therapies to patients in need." About Scinai Immunotherapeutics: Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a...
Jennifer Tamberino – who had been Regional Business Director, East, National Sales –was promoted to backfill Foy's former position as national sales director. "It is with incredible excitement that we announce Don's promotion to lead our sales,...
Ventures Company opens up completely new opportunities for us to tap into further markets, expand our technology platform and develop new products,” said Ulrike Sailer, CEO of Neoplas Med. “We are not only taking a big step forward, but also...
with latest pharma research and novel treatments on the horizon. In addition, a multidisciplinary approach to drug formulation and delivery will be presented. This conference features state of the art presentations and discussions on current...
in Houston, USA, from November 6 to 10. BH3120 is a novel anticancer drug based on Hanmi's proprietary dual antibody platform, "Pentambody." This technology enables a single antibody to simultaneously bind to two distinct targets, allowing for a...
You live every day not knowing what's going to happen." Terumo BCT makes the Spectra Optia™ Apheresis System, a platform used to collect and remove sickled cells from the blood of patients with SCD. The company advocates globally for patients with...
electrophysiological dysfunction of TDP-43 M337V mutated motor neurons, showcasing the potential for NUZ-001 to be a transformative treatment for ALS. Importantly, these findings reinforce the promising efficacy results seen in Neurizon's Phase 1...
Science: Advancements, Challenges, and Future Directions,” aiming to engage, empower, and develop new ideas in this platform for a better healthcare system. Attendees will have the unique opportunity to learn from leading experts in the field,...
Axonal.AI today unveiled its groundbreaking platform, designed to significantly accelerate speed to market in the life sciences industry. At a time when rapid commercialization is more critical than ever, Axonal.AI's cutting-edge technology...
(SCD) with recurrent vaso-occlusive crises or (2) transfusion-dependent β-thalassemia (TDT). Read the Full Prescribing Information here. "With our Cell and Gene Therapy Center of Excellence established over seven years ago, Orsini is...
frequent speaker and guest lecturer around the world. The privately-held company is based in Chicago, Illinois. For more information please visit www.ResQPharma.com.
organization with an efficient process-oriented approach and track record in the diagnostic imaging industry. For more information please visit, www.bracco.com
Chief Executive Officer of SystImmune, commented, "Our mission at SystImmune is to bring therapies that can provide transformative clinical benefit to patients. As BL-M17D1 is developed using our next generation linker and payload technology, the...
